The New York Stock Exchange (NYSE) has officially recognized the AdvisorShares Pure US Cannabis ETF, traded under the ticker symbol $MSOS. The acknowledgment was announced via a post on X (formerly Twitter) by the NYSE. Source

Significance of the Recognition

The NYSE's endorsement marks a notable development for cannabis-focused investment products. While the broader digital asset market has been sending mixed signals, this recognition underscores increasing institutional engagement with cannabis-related equities. The AdvisorShares Pure US Cannabis ETF is designed to offer investors exposure to the U.S. cannabis industry, a sector that has steadily attracted growing interest from both retail and institutional participants.

By granting formal recognition, the NYSE — one of the world's leading stock exchanges with authority over listed securities and ETFs — has lent additional credibility to cannabis as an investable asset class within mainstream finance.

About AdvisorShares

AdvisorShares is an asset management firm known for overseeing a diverse portfolio of exchange-traded funds, with a particular emphasis on emerging and specialized markets such as cannabis. The company's Pure US Cannabis ETF seeks to track companies operating in the U.S. cannabis space.

Market Response and Outlook

At the time of the announcement, no significant trading volume changes had been reported for the ETF, suggesting that market participants are still evaluating the implications of the NYSE's recognition. However, the acknowledgment is expected to raise the ETF's profile among institutional investors who may consider incorporating cannabis exposure into their portfolios.

The U.S. cannabis industry operates within a complex regulatory landscape: cannabis remains classified as a Schedule I substance at the federal level, even as over half of U.S. states have legalized recreational or medical use. In 2024, the DEA initiated a review process to potentially reclassify cannabis to Schedule III, a move that, if finalized, could affect tax treatment for cannabis companies under Internal Revenue Code Section 280E. Against this backdrop, ETFs like $MSOS provide one of the few vehicles for investors seeking exposure to companies operating directly within the U.S. market, as distinct from Canadian-focused cannabis funds that dominated the earlier ETF landscape.

Going forward, market observers will be monitoring trading dynamics, volume trends, and institutional participation in the ETF. Broader regulatory developments affecting the U.S. cannabis industry are also likely to play a role in shaping investor sentiment toward the sector.

This article is for informational purposes only and does not constitute financial advice.